Case-control study compares alpha 1-antitrypsin levels in aneurysm patients, revealing no significant associations.
Background: Alpha 1-antitrypsin (A1AT) helps maintain vascular-wall integrity, but its role in the formation and rupture of intracranial aneurysms is unclear. Objective: To compare A1AT levels between patients with ruptured and unruptured intracranial aneurysms and assess the associations with vasospasm and functional outcomes. Methods: We retrospectively analyzed the medical records of patients who had serum A1AT levels measured between 2018 and 2022 during routine outpatient evaluations. The sample included 233 patients with unruptured intracranial aneurysms, 114 with ruptured aneurysms, and 55 controls with intracranial arteriovenous malformations (AVMs), but without aneurysms. Results: = 0.23). Conclusion: The A1AT levels did not differ between the groups with ruptured and unruptured aneurysms, neither were they associated with vasospasm nor functional outcomes.
No takes yet. Share an insight, caveat, or question.
Júnior et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: